Huge profits may be unlikely, but Big Pharma may benefit from swine flu in other ways, says Trevor Huggins
After a busy summer of mergers and acquisitions, Sarah Wachter asks where Big Pharma is going and why?
Two dentists from Zürich have turned the profession on its head and are now exporting the results, says Richard Lofthouse